New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife System

Source :: PR Newswire. March 26, 2024
Publication Year :: 2024
Abstract: Data Also Underscores Potential Benefits of CyberKnife System Sub-millimeter Accuracy in Preserving Quality of Life after Treatment for Prostate Cancer MADISON, Wis., March 26, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: [...]

Subjects :: Oncology, Experimental -- Health aspects
Prostate cancer -- Risk factors -- Care and treatment
Diseases -- Relapse
Clinical trials -- Health aspects
Medical care -- Quality management
Cancer -- Research
Business
News, opinion and commentary

Tools